Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306155207> ?p ?o ?g. }
- W4306155207 endingPage "1462" @default.
- W4306155207 startingPage "1455" @default.
- W4306155207 abstract "Primary mucinous ovarian cancer is a rare type of epithelial ovarian cancer. In this comprehensive review we discuss management recommendations for the treatment of mucinous ovarian cancer. Although most tumors are stage I at diagnosis, 15–20% are advanced stage at diagnosis. Traditionally, patients with primary mucinous ovarian cancer have been treated similarly to those with the more common serous ovarian cancer. However, recent studies have shown that mucinous ovarian cancer is very different from other types of epithelial ovarian cancer. Primary mucinous ovarian cancer is less likely to spread to lymph nodes or the upper abdomen and more likely to affect younger women, who may desire fertility-sparing therapies. Surgical management of mucinous ovarian cancer mirrors surgical management of other types of epithelial ovarian cancer and includes a bilateral salpingo-oophorectomy and total hysterectomy. When staging is indicated, it should include pelvic washing, omentectomy, and peritoneal biopsies; lymph node evaluation should be considered in patients with infiltrative tumors. The appendix should be routinely evaluated intra-operatively, but an appendectomy may be omitted if the appendix appears grossly normal. Fertility preservation can be considered in patients with gross disease confined to one ovary and a normal-appearing contralateral ovary. Patients with recurrent platinum-sensitive disease whose disease distribution suggests a high likelihood of complete gross resection may be candidates for secondary debulking. Primary mucinous ovarian cancer seems to be resistant to standard platinum-and-taxane regimens used frequently for other types of ovarian cancer. Gastrointestinal cancer regimens are another option; these include 5-fluorouracil and oxaliplatin, or capecitabine and oxaliplatin. Data on heated intra-peritoneal chemotherapy (HIPEC) for mucinous ovarian cancer are scarce, but HIPEC may be worth considering. For patients with recurrence or progression on first-line chemotherapy, we advocate enrollment in a clinical trial if one is available. For this reason, it may be beneficial to perform molecular testing in all patients with recurrent or progressive mucinous ovarian cancer." @default.
- W4306155207 created "2022-10-14" @default.
- W4306155207 creator A5066584153 @default.
- W4306155207 creator A5082358197 @default.
- W4306155207 date "2022-10-13" @default.
- W4306155207 modified "2023-10-11" @default.
- W4306155207 title "Primary mucinous ovarian cancer: options for surgery and chemotherapy" @default.
- W4306155207 cites W1860655878 @default.
- W4306155207 cites W1863225814 @default.
- W4306155207 cites W1899821637 @default.
- W4306155207 cites W1940241680 @default.
- W4306155207 cites W1942713680 @default.
- W4306155207 cites W1965582784 @default.
- W4306155207 cites W1968709262 @default.
- W4306155207 cites W1990889322 @default.
- W4306155207 cites W2003447400 @default.
- W4306155207 cites W2014920648 @default.
- W4306155207 cites W2018480903 @default.
- W4306155207 cites W2045639152 @default.
- W4306155207 cites W2047494773 @default.
- W4306155207 cites W2048623699 @default.
- W4306155207 cites W2050333705 @default.
- W4306155207 cites W2058271799 @default.
- W4306155207 cites W2066406907 @default.
- W4306155207 cites W2088899370 @default.
- W4306155207 cites W2089820081 @default.
- W4306155207 cites W2096412326 @default.
- W4306155207 cites W2097198751 @default.
- W4306155207 cites W2105438110 @default.
- W4306155207 cites W2106767659 @default.
- W4306155207 cites W2113122060 @default.
- W4306155207 cites W2118228232 @default.
- W4306155207 cites W2123549115 @default.
- W4306155207 cites W2123696077 @default.
- W4306155207 cites W2128904109 @default.
- W4306155207 cites W2133386277 @default.
- W4306155207 cites W2147539392 @default.
- W4306155207 cites W2156691266 @default.
- W4306155207 cites W2168893449 @default.
- W4306155207 cites W2222529560 @default.
- W4306155207 cites W2301075047 @default.
- W4306155207 cites W2328421677 @default.
- W4306155207 cites W2499368352 @default.
- W4306155207 cites W2549240344 @default.
- W4306155207 cites W2549479337 @default.
- W4306155207 cites W2597159340 @default.
- W4306155207 cites W2749595139 @default.
- W4306155207 cites W2752500234 @default.
- W4306155207 cites W2760564157 @default.
- W4306155207 cites W2767250946 @default.
- W4306155207 cites W2774559127 @default.
- W4306155207 cites W2784597821 @default.
- W4306155207 cites W2792168966 @default.
- W4306155207 cites W2794839527 @default.
- W4306155207 cites W2797417034 @default.
- W4306155207 cites W2802324884 @default.
- W4306155207 cites W2803559446 @default.
- W4306155207 cites W2915944698 @default.
- W4306155207 cites W2924865772 @default.
- W4306155207 cites W2936836467 @default.
- W4306155207 cites W2945732187 @default.
- W4306155207 cites W2946553175 @default.
- W4306155207 cites W2946899828 @default.
- W4306155207 cites W2970379806 @default.
- W4306155207 cites W2985168992 @default.
- W4306155207 cites W2988241615 @default.
- W4306155207 cites W2996972368 @default.
- W4306155207 cites W3002194007 @default.
- W4306155207 cites W3010742273 @default.
- W4306155207 cites W3012380787 @default.
- W4306155207 cites W3023274953 @default.
- W4306155207 cites W3033406760 @default.
- W4306155207 cites W3066362485 @default.
- W4306155207 cites W3092412842 @default.
- W4306155207 cites W3126104714 @default.
- W4306155207 cites W3134618328 @default.
- W4306155207 cites W3135376158 @default.
- W4306155207 cites W3154846412 @default.
- W4306155207 cites W3163685580 @default.
- W4306155207 cites W3193026281 @default.
- W4306155207 cites W4226453968 @default.
- W4306155207 doi "https://doi.org/10.1136/ijgc-2022-003806" @default.
- W4306155207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36229081" @default.
- W4306155207 hasPublicationYear "2022" @default.
- W4306155207 type Work @default.
- W4306155207 citedByCount "5" @default.
- W4306155207 countsByYear W43061552072023 @default.
- W4306155207 crossrefType "journal-article" @default.
- W4306155207 hasAuthorship W4306155207A5066584153 @default.
- W4306155207 hasAuthorship W4306155207A5082358197 @default.
- W4306155207 hasBestOaLocation W43061552071 @default.
- W4306155207 hasConcept C121608353 @default.
- W4306155207 hasConcept C126322002 @default.
- W4306155207 hasConcept C143998085 @default.
- W4306155207 hasConcept C150173356 @default.
- W4306155207 hasConcept C2776694085 @default.
- W4306155207 hasConcept C2777874381 @default.
- W4306155207 hasConcept C2778764654 @default.